SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q1 2022$400,000
+28.2%
13,3940.0%0.01%0.0%
Q4 2021$312,000
-39.1%
13,394
-18.4%
0.01%
-11.1%
Q3 2021$512,000
-27.9%
16,408
-18.7%
0.01%
-30.8%
Q2 2021$710,000
-21.0%
20,188
-20.8%
0.01%
-13.3%
Q1 2021$899,000
+4.2%
25,500
+10.9%
0.02%
-6.2%
Q4 2020$863,000
+23.8%
23,001
+10.1%
0.02%
-23.8%
Q3 2020$697,00020,9000.02%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Prosight Management, LP 480,000$14,318,0009.25%
Decheng Capital Management III (Cayman), LLC 518,342$15,462,0004.74%
TANG CAPITAL MANAGEMENT LLC 467,702$13,952,0002.79%
Birchview Capital, LP 113,000$3,371,0002.43%
Privium Fund Management B.V. 351,805$10,494,0002.32%
Sio Capital Management, LLC 144,546$4,312,0001.43%
Perceptive Advisors 2,360,139$70,403,0001.41%
Chicago Capital, LLC 1,011,744$30,180,0001.30%
Endurant Capital Management LP 120,834$3,604,0000.95%
Nicholas Investment Partners, LP 439,235$13,102,0000.93%
View complete list of ALBIREO PHARMA INC shareholders